Established in 1990, Bionique Testing Laboratories is an independent, FDA-registered contract testing laboratory that is exclusively dedicated to mycoplasma testing and consulting services. Bionique is one of the very few testing laboratories in the world uniquely specialized in mycoplasma testing and is a recognized leader in the field. The company has experienced an increase in its workforce of 25% since 2018 and as a result of the mycoplasma industry’s projected growth rate of 12.5% per year over the next 5 years, is on the verge of serious growth that will result in the further expansion of its workforce and the need for additional space.
Since the outbreak of COVID-19, the Bionique team has been working to keep their employees safe and has built in redundant safety procedures to ensure safety. By modifying quality systems, they have even further minimized contamination risk. Work shifts have expanded and there are fewer people in the facility at any one time in accordance with social distancing guidelines; employees who are able, are working offsite. The company anticipates growth projections to remain stable.
In addition to past training programs, WDI is assisting the company with its investment in equipment that will enable improved efficiencies and will increase the scalability of production. WDI has also connected Bionique with several partners in the North Country to help them prepare for and manage the company’s coming expansion.
